Crossmark

Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney disease

Crossref DOI link: https://doi.org/10.1007/s00467-017-3787-0

Published Online: 2017-09-12

Published Print: 2018-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fathallah-Shaykh, Sahar

Drozdz, Dorota

Flynn, Joseph

Jenkins, Randall

Wesseling-Perry, Katherine

Swartz, Sarah J.

Wong, Craig

Accomando, Beverly

Cox, Gerald F.

Warady, Bradley A.
Funding

Funding for this research was provided by:

Sanofi
License Information

License valid from 2017-09-12